Zobrazeno 1 - 10
of 130
pro vyhledávání: '"B. B. Besse"'
Autor:
D. S. Chen, D. M. Feltquate, F. Smothers, A. Hoos, S. Langermann, S. Marshall, R. May, M. Fleming, F. S. Hodi, A. Senderowicz, K. G. Wiman, S. de Dosso, W. Fiedler, L. Gianni, S. Cresta, H. B. Schulze-Bergkamen, L. Gurrieri, M. Salzberg, B. Dietrich, A. Danielczyk, H. Baumeister, S. Goletz, C. Sessa, D. Strumberg, B. Schultheis, A. Santel, F. Gebhardt, W. Meyer-Sabellek, O. Keil, K. Giese, J. Kaufmann, M. Maio, G. Choy, A. Covre, G. Parisi, H. Nicolay, E. Fratta, E. Fonsatti, L. Sigalotti, S. Coral, P. Taverna, M. Azab, E. Deutsch, C. Lepechoux, J. P. Pignon, Y. T. Tao, S. Rivera, B. C. Bourgier, M. Angokai, R. Bahleda, K. Slimane, E. Angevin, B. B. Besse, J. C. Soria, K. Dragnev, J. H. Beumer, B. Anyang, T. Ma, F. Galimberti, C. P. Erkmen, W. Nugent, J. Rigas, K. Abraham, D. Johnstone, V. Memoli, E. Dmitrovsky, E. E. Voest, L. Siu, F. Janku, A. Tsimberidou, R. Kurzrock, J. Tabernero, J. Rodon, R. Berger, A. Onn, G. Batist, C. Bresson, V. Lazar, J. J. Molenaar, J. Koster, M. Ebus, D. A. Zwijnenburg, P. van Sluis, F. Lamers, L. Schild, I. van der Ploeg, H. N. Caron, R. Versteeg, J. Pouyssegur, I. Marchiq, J. Chiche, D. Roux, R. Le Floch, S. E. Critchlow, R. F. Wooster, S. Agresta, K. E. Yen, P. A. Janne, E. R. Plummer, G. Trinchieri, L. Ellis, S. L. Chan, W. Yeo, A. T. Chan, F. Mouliere, S. El Messaoudi, C. Gongora, P. J. Lamy, M. del Rio, E. Lopez-Crapez, B. Gillet, M. Mathonnet, D. Pezet, M. Ychou, A. R. Thierry, V. Ribrag, W. Vainchenker, S. Constantinescu, H. Keilhack, I. A. Umelo, A. Noeparast, G. Chen, M. Renard, C. Geers, J. Vansteenkiste, E. Teugels, J. de Greve, O. Rixe, X. Qi, Z. Chu, J. Celerier, L. Leconte, N. Minet, J. Pakradouni, B. Kaur, F. Cuttitta, A. J. Wagner, Y. X. Zhang, E. Sicinska, J. T. Czaplinski, S. P. Remillard, G. D. Demetri, S. Weng, L. Debussche, L. Agoni, E. P. Reddy, C. Guha, K. Silence, A. Thibault, H. de Haard, T. Dreier, P. Ulrichts, M. Moshir, S. Gabriels, J. Luo, C. Carter, A. Rajan, S. Khozin, A. Thomas, A. Lopez-Chavez, C. Brzezniak, L. Doyle, C. Keen, M. Manu, M. Raffeld, G. Giaccone, S. Lutzker, J. M. Melief, S. G. Eckhardt, L. Trusolino, G. Migliardi, E. R. Zanella, F. Cottino, F. Galimi, F. Sassi, S. Marsoni, P. M. Comoglio, A. Bertotti, M. Hidalgo, S. J. Weroha, P. Haluska, M. A. Becker, S. C. Harrington, K. M. Goodman, S. E. Gonzalez, M. al Hilli, K. A. Butler, K. R. Kalli, A. L. Oberg, I. J. Huijbers, R. Bin Ali, C. Pritchard, M. Cozijnsen, N. Proost, J. Y. Song, P. Krimpenfort, E. Michalak, J. Jonkers, A. Berns, U. Banerji, A. Stewart, P. Thavasu, S. Banerjee, S. B. Kaye
Publikováno v:
Annals of Oncology. 24:i7-i17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::035ed0eff9eb1a7df4f5f8bb1d940b6b
https://doi.org/10.1093/annonc/mdt042
https://doi.org/10.1093/annonc/mdt042
Autor:
McDaid WJ; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK., Wilson L; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK., Adderley H; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK., Martinez-Lopez A; Department of Biochemistry and Molecular Biology, Faculty of Chemical Sciences, Complutense University of Madrid, Madrid, Spain., Baker MJ; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK., Searle J; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK., Ginn L; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK., Budden T; Skin Cancer and Ageing Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK., Aldea M; Paris Saclay University, Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Marinello A; Paris Saclay University, Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Aredo JV; Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA., Viros A; Skin Cancer and Ageing Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK., Besse B; Paris Saclay University, Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Wakelee HA; Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA., Blackhall F; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK., Castillo-Lluva S; Department of Biochemistry and Molecular Biology, Faculty of Chemical Sciences, Complutense University of Madrid, Madrid, Spain., Lindsay CR; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK. colin.lindsay@manchester.ac.uk.; The Christie NHS Foundation Trust, Manchester, UK. colin.lindsay@manchester.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK. colin.lindsay@manchester.ac.uk., Malliri A; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK. Angeliki.Malliri@manchester.ac.uk.; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK. Angeliki.Malliri@manchester.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK. Angeliki.Malliri@manchester.ac.uk.
Publikováno v:
Molecular cancer [Mol Cancer] 2024 Nov 12; Vol. 23 (1), pp. 253. Date of Electronic Publication: 2024 Nov 12.
Autor:
Sánchez Becerra MV; 'Rare Circulating Cells' Translational Platform, Gustave Roussy, Université Paris-Saclay, CNRS UMS3655-INSERM US23 AMMICA, Villejuif; 'Identification of Molecular Predictors and new Targets for Cancer Treatment'. INSERM, U981, Villejuif; Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Escudero Iriarte C; Upper GI and Endocrine Tumor Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Travert C; Thoracic Oncology Department, Hôpital Arnaud de Villeneuve-Centre Hospitalier, Universitaire de Montpellier, Montpellier, France., Tian TV; Thoracic Oncology Department, Hôpital Arnaud de Villeneuve-Centre Hospitalier, Universitaire de Montpellier, Montpellier, France., Besse B; 'Rare Circulating Cells' Translational Platform, Gustave Roussy, Université Paris-Saclay, CNRS UMS3655-INSERM US23 AMMICA, Villejuif; 'Identification of Molecular Predictors and new Targets for Cancer Treatment'. INSERM, U981, Villejuif; Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France. Electronic address: benjamin.besse@gustaveroussy.fr.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Oct 11. Date of Electronic Publication: 2024 Oct 11.
Autor:
Harris E; Department of Medicine, University of Chicago, Chicago, USA., Taflin NF; Division of Oncology, Department of Internal Medicine, University of Utah, Salt Lake City, USA., Chitkara A; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA., Tagliamento M; Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy; Department of Oncology and Hematology, Academic Medical Oncology Unit, IRCCS San Martino Hospital, Genoa, Italy., Bestvina CM; Section of Hematology/Oncology, University of Chicago, Chicago, USA., Vakkalagadda CV; Division of Hematology & Oncology, Oregon Health & Sciences University, Portland, USA., Besse B; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Thawani R; Section of Hematology/Oncology, University of Chicago, Chicago, USA. Electronic address: Rajat.thawani@bsd.uchicago.edu.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Oct 11. Date of Electronic Publication: 2024 Oct 11.
Autor:
Felip E; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Universitat Autonoma de Barcelona, Barcelona, Spain. Electronic address: efelip@vhio.net., Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Gutiérrez V; Medical Oncology Department, Hospital Regional Universitario de Málaga y Virgen de la Victoria, IBIMA, Málaga, Spain., Alip A; Clinical Oncology Unit, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Besse B; Paris-Saclay University, Gustave Roussy, Villejuif, France., Lu S; Shanghai Lung Cancer Center, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China., Spira AI; Virginia Cancer Specialists, Fairfax, VA, USA., Girard N; Institut du Thorax Curie-Montsouris, Paris, France; Paris Saclay University, Université de Versailles Saint-Quentin-en-Yvelines, Versailles, France., Califano R; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Gadgeel SM; Department of Internal Medicine, Henry Ford Cancer Institute, Detroit, MI, USA., Yang JC; National Taiwan University Cancer Center and National Taiwan University Hospital, Taipei, Taiwan., Yamamoto S; Ehime University Hospital, Toon, Ehime., Azuma K; Kurume University School of Medicine, Kurume, Japan., Kim YJ; Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea., Lee KH; Medical Department, Chungbuk National University Hospital, Cheongju, Republic of Korea., Danchaivijitr P; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand., Ferreira CG; Oncoclinicas&CO/MedSir, Rio de Janeiro, Brazil., Cheng Y; Jilin Cancer Hospital, Changchun, China., Sendur MAN; Department of Medical Oncology, Ankara Bilkent City Hospital and Ankara Yıldırım Beyazıt University, Ankara, Turkey., Chang GC; School of Medicine and Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan., Wang CC; Division of Pulmonary & Critical Care Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan., Prabhash K; Department of Medical Oncology, Tata Memorial Centre, HBNI, Mumbai, India., Shinno Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Stroyakovskiy D; Healthcare Department, Moscow City Oncology Hospital No. 62, Moscow, Russia., Paz-Ares L; CNIO-H120 Lung Cancer Unit, University Hospital 12 de Octubre, Universidad Complutense de Madrid and CIBERONC, Madrid, Spain., Rodriguez-Cid JR; Médica Sur, Ciudad de México, CDMX, Mexico., Martin C; Thoracic Oncology Unit and Clinical Research Unit, Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Campelo MRG; Medical Oncology, Hospital Universitario A Coruña, A Coruña, Spain., Hayashi H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan., Nguyen D; City of Hope National Medical Center, Duarte, CA, USA., Tomasini P; Aix Marseille University, APHM, INSERM, NCRS, CRCM, Hôpital de la Timone, Multidisciplinary Oncology & Therapeutic Innovations Department, Marseille, France., Gottfried M; Meir Medical Center, Kfar-Sava, Israel., Dooms C; Respiratory Oncology Unit, University Hospitals Leuven, Leuven, Belgium., Passaro A; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan, Italy., Schuler M; West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen, Germany., Gelatti ACZ; Uniao Brasileira de Educaçao e Assistencia-Hospital Sao Lucas da PUCRS, Porto Alegre-RS, Brazil., Owen S; Department of Oncology, McGill University, Montréal, QC, Canada., Perdrizet K; William Osler Health System, Brampton, ON, Canada., Ou SI; Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, CA, USA., Curtin JC; Janssen Research & Development, Spring House, PA, USA., Zhang J; Janssen Research & Development, Spring House, PA, USA., Gormley M; Janssen Research & Development, Spring House, PA, USA., Sun T; Janssen Research & Development, Raritan, NJ, USA., Panchal A; Janssen Research & Development, High Wycombe, UK., Ennis M; Janssen Research & Development, Spring House, PA, USA., Fennema E; Janssen Research & Development, San Diego, CA, USA., Daksh M; Janssen Research & Development, Raritan, NJ, USA., Sethi S; Janssen Research & Development, Spring House, PA, USA., Bauml JM; Janssen Research & Development, Spring House, PA, USA., Lee SH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Sep; Vol. 35 (9), pp. 805-816. Date of Electronic Publication: 2024 Jun 26.
Autor:
Bayle A; Bureau Biostatistique et Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM, Université Paris-Saclay, CESP U1018 Oncostat, Labelisé Ligue Contre le Cancer, Villejuif, France; European Society for Medical Oncology (ESMO), Lugano, Switzerland. Electronic address: arnaud.bayle@gustaveroussy.fr., Chaltiel D; Bureau Biostatistique et Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM, Université Paris-Saclay, CESP U1018 Oncostat, Labelisé Ligue Contre le Cancer, Villejuif, France., Latino N; European Society for Medical Oncology (ESMO), Lugano, Switzerland., Rouleau E; Department of Medical Biology and Pathology, Tumor Genetic Lab, Gustave Roussy, Villejuif; INSERM UMR 981, Gustave Roussy, Villejuif, France., Peters S; European Society for Medical Oncology (ESMO), Lugano, Switzerland; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Galotti M; European Society for Medical Oncology (ESMO), Lugano, Switzerland., Bricalli G; European Society for Medical Oncology (ESMO), Lugano, Switzerland., Besse B; Faculté de Médicine, Université Paris-Saclay, Université Paris-Sud, Paris; Department of Cancer Medicine, Gustave Roussy, Paris-Saclay University, Villejuif, France., Giuliani R; European Society for Medical Oncology (ESMO), Lugano, Switzerland; Guy's and St Thomas NHS Foundation Trust, London, UK., Bonastre J; Bureau Biostatistique et Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM, Université Paris-Saclay, CESP U1018 Oncostat, Labelisé Ligue Contre le Cancer, Villejuif, France.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Sep; Vol. 35 (9), pp. 829-830. Date of Electronic Publication: 2024 Jun 06.
Autor:
Besse B; Paris-Saclay University, Cancer Medicine Department, Institut Gustave Roussy, Villejuif, France. Electronic address: Benjamin.BESSE@gustaveroussy.fr., Felip E; Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona., Garcia Campelo R; Medical Oncology Department, Complejo Hospitalario Universitario A Coruña, Biomedical Research Institute, INIBIC, A Coruña., Cobo M; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain., Mascaux C; Pneumology Department, Hôpitaux Universitaires de Strasbourg-Nouvel Hôpital Civil, Strasbourg., Madroszyk A; Medical Oncology Department, IPC-Institut Paoli-Calmettes, Marseille, France., Cappuzzo F; Oncology Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Hilgers W; Medical Oncology Department, Sainte Catherine Cancer Center, Avignon, France., Romano G; Medical Oncology Department, Ospedale Vito Fazzi-ASL Lecce, Lecce, Italy., Denis F; Medical Oncology Department, Institut Inter-Régional de Cancérologie Jean Bernard-Elsan, Le Mans, France., Viteri S; Medical Oncology Department, Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Grupo Quironsalud, Barcelona, Spain., Debieuvre D; Pneumology Department, Groupe Hospitalier de la Région Mulhouse Sud Alsace, Mulhouse, France., Galetta D; Medical Thoracic Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari., Baldini E; Oncology Department, Ospedale San Luca, Lucca, Italy., Razaq M; Oncology Department, Stephenson Cancer Center, Oklahoma City, USA., Robinet G; Oncology Department, Centre Hospitalier Régional Universitaire Morvan, Brest, France., Maio M; Department of Oncology, University of Siena and Center for Immuno-Oncology, University Hospital, Siena., Delmonte A; Thoracic Department, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST), Meldola, Italy., Roch B; Thoracic Oncology Unit, Montpellier University, University Hospital of Montpellier, Montpellier., Masson P; Pneumology Department, Centre Hospitalier de Cholet, Cholet, France., Schuette W; Medical Oncology Department, Hospital Martha-Maria Halle-Doelau, Halle, Germany., Zer A; Thoracic Cancer Service, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel., Remon J; Paris-Saclay University, Cancer Medicine Department, Institut Gustave Roussy, Villejuif, France., Costantini D; Medical Development Department, OSE Immunotherapeutics, Paris, France., Vasseur B; Medical Development Department, OSE Immunotherapeutics, Paris, France., Dziadziuszko R; Oncology and Radiotherapy Department and Early Phase Clinical Trials Centre, Medical University of Gdansk, Gdansk, Poland., Giaccone G; Meyer Cancer Center, Weill Cornell Medicine, New York, USA.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Oct; Vol. 34 (10), pp. 920-933. Date of Electronic Publication: 2023 Sep 11.
ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe.
Autor:
Bayle A; Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, Villejuif; Université Paris Saclay, Université Paris-Sud, Faculté de Médicine, Le Kremlin Bicêtre, Paris; Bureau Biostatistique et Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM, Université Paris-Saclay, CESP U1018 Oncostat, Labelisé Ligue Contre le Cancer, Villejuif, France; European Society for Medical Oncology (ESMO), Lugano, Switzerland. Electronic address: Arnaud.bayle@gustaveroussy.fr., Bonastre J; Bureau Biostatistique et Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM, Université Paris-Saclay, CESP U1018 Oncostat, Labelisé Ligue Contre le Cancer, Villejuif, France., Chaltiel D; Bureau Biostatistique et Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM, Université Paris-Saclay, CESP U1018 Oncostat, Labelisé Ligue Contre le Cancer, Villejuif, France., Latino N; European Society for Medical Oncology (ESMO), Lugano, Switzerland., Rouleau E; Department of Medical Biology and Pathology, Tumor Genetic Lab, Gustave Roussy, Villejuif; INSERM UMR 981, Gustave Roussy, Villejuif, France., Peters S; European Society for Medical Oncology (ESMO), Lugano, Switzerland; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Galotti M; European Society for Medical Oncology (ESMO), Lugano, Switzerland., Bricalli G; European Society for Medical Oncology (ESMO), Lugano, Switzerland., Besse B; Université Paris Saclay, Université Paris-Sud, Faculté de Médicine, Le Kremlin Bicêtre, Paris; Paris-Saclay University, Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Giuliani R; European Society for Medical Oncology (ESMO), Lugano, Switzerland; Guy's and St Thomas NHS Foundation Trust, London, UK.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Oct; Vol. 34 (10), pp. 934-945. Date of Electronic Publication: 2023 Jul 03.
Autor:
Remon J; Paris-Saclay University, Institut Gustave Roussy, Villejuif, France., Besse B; Paris-Saclay University, Institut Gustave Roussy, Villejuif, France., Aix SP; Hospital Universitario 12 De Octubre, Madrid, Spain., Callejo A; Hospital Universitari Vall d'Hebron-Vall d'Hebron Institut Oncologia, Barcelona, Spain., Al-Rabi K; King Hussein Cancer Center, Amman, Jordan., Bernabe R; University Hospital Virgen del Rocio, Seville, Spain., Greillier L; Aix Marseille University, Assitance Publique-Hôpitaux de Marseille (APHM), Marseille, France., Majem M; Hospital De La Santa Creu I Sant Pau, Barcelona, Spain., Reguart N; Hospital Clinic Universitari de Barcelona, IDIBAPS, Barcelona, Spain., Monnet I; Centre Hospitalier Intercommunal De Creteil, Creteil, France., Cousin S; Institut Bergonie, Bordeaux, France., Garrido P; Hospital Universitario Ramon y Cajal, Madrid, Spain., Robinet G; CHU de Brest, Brest, France., Garcia Campelo R; University Hospital A Coruna-Hospital Teresa Herrera, A Coruna, Spain., Madroszyk A; Institut Paoli-Calmettes, Marseille, France., Mazières J; CHU de Toulouse - Hopital Larrey, Toulouse, France., Curcio H; Centre François Baclesse, CHU Côte de Nacre, Caen, France., Wasąg B; Medical University of Gdansk, Gdansk, Poland., Pretzenbacher Y; EORTC Headquarters, Brussels, Belgium., Fournier B; EORTC Headquarters, Brussels, Belgium., Dingemans AC; Erasmus Medical Center, Rotterdam, Netherlands., Dziadziuszko R; Medical University of Gdansk, Gdansk, Poland. Electronic address: rafald@gumed.edu.pl.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 May; Vol. 34 (5), pp. 468-476. Date of Electronic Publication: 2023 Feb 28.
Autor:
Bayle A; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif; Université Paris-Saclay, Faculté de médecine, Le Kremlin Bicêtre, Paris; Oncostat U1018, Inserm, Paris-Saclay University, labeled Ligue Contre le Cancer, Villejuif, France., Belcaid L; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Aldea M; Department of Cancer Medicine, Gustave Roussy, Villejuif., Vasseur D; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif., Peyraud F; Department of Early Phase Trial Unit, Institut Bergonié Comprehensive Cancer Centre, Bordeaux., Nicotra C; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif., Geraud A; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif., Sakkal M; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif., Seknazi L; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif., Cerbone L; Department of Cancer Medicine, Gustave Roussy, Villejuif., Blanc-Durand F; Department of Cancer Medicine, Gustave Roussy, Villejuif., Hadoux J; Department of Cancer Medicine, Gustave Roussy, Villejuif., Mosele F; Department of Cancer Medicine, Gustave Roussy, Villejuif., Tagliamento M; Department of Cancer Medicine, Gustave Roussy, Villejuif., Bernard-Tessier A; Department of Cancer Medicine, Gustave Roussy, Villejuif., Verret B; Université Paris-Saclay, Faculté de médecine, Le Kremlin Bicêtre, Paris; Department of Cancer Medicine, Gustave Roussy, Villejuif., Smolenschi C; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif., Clodion R; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif., Auger N; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif., Romano PM; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif., Gazzah A; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif., Camus MN; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif., Micol J; Department of Hematology, Gustave Roussy, Villejuif., Caron O; Department of Genetics, Gustave Roussy, Villejuif., Hollebecque A; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif., Loriot Y; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif., Besse B; Université Paris-Saclay, Faculté de médecine, Le Kremlin Bicêtre, Paris; Department of Cancer Medicine, Gustave Roussy, Villejuif., Lacroix L; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif., Rouleau E; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif., Ponce S; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif., Soria JC; Université Paris-Saclay, Faculté de médecine, Le Kremlin Bicêtre, Paris; Department of Cancer Medicine, Gustave Roussy, Villejuif., Barlesi F; Université Paris-Saclay, Faculté de médecine, Le Kremlin Bicêtre, Paris; Department of Cancer Medicine, Gustave Roussy, Villejuif., Andre F; Université Paris-Saclay, Faculté de médecine, Le Kremlin Bicêtre, Paris; Department of Cancer Medicine, Gustave Roussy, Villejuif., Italiano A; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif; Department of Early Phase Trial Unit, Institut Bergonié Comprehensive Cancer Centre, Bordeaux; Faculty of Medicine, University of Bordeaux, Bordeaux, France. Electronic address: Antoine.italiano@gustaveroussy.fr.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Apr; Vol. 34 (4), pp. 389-396. Date of Electronic Publication: 2023 Jan 25.